Product: GlipiZIDE Extended-Release Tablets, 2.5 mg, 30 Tablets (3 blister cards each with 10 individually blistered doses), Rx only, Manufactured by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054.  Carton NDC#: 68084-295-21 (Individual Dose NDC: 68084-295-11)
Reason for recall: Failed Dissolution Specifications: results were above specification.
Recall initiated: 20210917
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated